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Abstract
Background: The Thymidine kinase (Tk) mutants generated from the widely used L5178Y mouse lymphoma assay fall
into two categories, small colony and large colony. Cells from the large colonies grow at a normal rate while cells from
the small colonies grow slower than normal. The relative proportion of large and small colonies after mutagen treatment
is associated with a mutagen's ability to induce point mutations and/or chromosomal mutations. The molecular
distinction between large and small colony mutants, however, is not clear.
Results: To gain insights into the underlying mechanisms responsible for the mutant colony phenotype, microarray gene
expression analysis was carried out on 4 small and 4 large colony Tk  mutant samples. NCTR-fabricated long-
oligonucleotide microarrays of 20,000 mouse genes were used in a two-color reference design experiment. The data
were analyzed within ArrayTrack software that was developed at the NCTR. Principal component analysis and
hierarchical clustering of the gene expression profiles showed that the samples were clearly separated into two groups
based on their colony size phenotypes. The Welch T-test was used for determining significant changes in gene expression
between the large and small colony groups and 90 genes whose expression was significantly altered were identified (p <
0.01; fold change > 1.5). Using Ingenuity Pathways Analysis (IPA), 50 out of the 90 significant genes were found in the IPA
database and mapped to four networks associated with cell growth. Eleven percent of the 90 significant genes were
located on chromosome 11 where the Tk gene resides while only 5.6% of the genes on the microarrays mapped to
chromosome 11. All of the chromosome 11 significant genes were expressed at a higher level in the small colony mutants
compared to the large colony mutants. Also, most of the significant genes located on chromosome 11 were
disproportionally concentrated on the distal end of chromosome 11 where the Tk mutations occurred.
Conclusion: The results indicate that microarray analysis can define cellular phenotypes and identify genes that are
related to the colony size phenotypes. The findings suggest that genes in the DNA segment altered by the Tk mutations
were significantly up-regulated in the small colony mutants, but not in the large colony mutants, leading to differential
expression of a set of growth regulation genes that are related to cell apoptosis and other cellular functions related to
the restriction of cell growth.
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Background
The mouse lymphoma assay (MLA) is used internation-
ally for regulatory decision-making and it is the mamma-
lian in vitro gene mutation assay preferred by the U.S.
FDA, the U.S. EPA, and the International Committee on
Harmonization (including the European, Japanese and
U.S. pharmaceutical companies and regulatory agencies)
[1-3]. The MLA is conducted using an L5178Y cell line that
is heterozygous for the Tk gene. The assay detects forward
mutation of the wild-type Tk  allele (Tk1b) located on
mouse chromosome 11 [4]. In this assay, Tk-deficient (Tk-
/- or Tk0/-) mutants of the L5178Y/Tk+/- mouse lymphoma
cells are selected by the pyrimidine analog trifluorothymi-
dine (TFT) because TFT inhibits division of the Tk compe-
tent (Tk+/-) cells that are capable of incorporating TFT into
the DNA. The mutant cells cannot incorporate TFT into
their DNA because of the Tk gene deficiency. Therefore,
the mutants can grow and develop into colonies in the
selective growth medium while the Tk-competent cells are
growth arrested and do not divide.
A striking feature of the Tk mutant colonies recovered in
the MLA is the presence of two size classes of mutants.
Immediately following their isolation, the cells in the
large colonies grow at a normal rate, while cells in the
small colonies grow slowly. The relative frequency of the
two colony classes is mutagen dependent. Generally, clas-
togens induce more small colony mutants while point
mutagens induce more large colony mutants [5-8]. It
should be noted that many chemicals induce both small
and large colony mutants.
It is important to obtain definitive information concern-
ing the underlying molecular basis for the small and large
colony mutant phenotype. This can be particularly impor-
tant in a regulatory context. There is increasing interest in
distinguishing between chemicals that cause point muta-
tions and those that cause chromosomal mutants. The
small and large colony Tk mutant phenotype was identi-
fied more than 30 years ago and there have been several
hypotheses proposed to explain the difference between
these two mutant types. The first one suggested that the
small-colony mutants result from large scale damage to
the chromosome 11b on which the Tk+ allele resides while
large-colony mutants result from mutational events affect-
ing the expression of only the Tk gene [9-11]. This hypo-
thesis was expanded to state that small colony mutants are
the consequence of intergenic lesions affecting the Tk gene
and other putative growth control gene(s) that may or
may not be on chromosome 11. Large colony mutants are
the consequence of either intragenic lesions limited to the
Tk gene or intergenic lesions that do not affect the growth
control gene [12,13]. So far, the growth control gene or
genes have not been identified. Further analysis using
microsatellite markers on chromosome 11 demonstrated
that both large and small colony mutants can apparently
have relatively large alterations of chromosome 11b
[14,15]. Also, it is clear that the entire chromosome 11b is
lost in some large colony mutants [15]. Another possible
hypothesis, demonstrated in other cell types, invokes a
process of chromosome damage and repair. In this model,
a cell with chromosome damage would suffer arrested
growth until the cell repairs the damage [16,17]. None of
these hypotheses, however, can fully explain the differ-
ence between the small and large colony phenotypes
because the molecular analysis of mutants (primarily mic-
rosatellite analysis) does not reveal a clear cut distinction
in the degree of "damage" between small and large colony
mutants. That is, the fundamental mechanistic differ-
ence(s) between the small and large colony mutant phe-
notypes has not been elucidated using the available
analytical techniques.
The advent of gene microarrays permits the analysis of
gene expression for thousands of genes simultaneously in
biological samples of interest, permitting functional inter-
pretation of the transcriptome state of any given cell type
at a particular physiologic state [18,19]. These cellular
mRNA expression profiles yield global genomic finger-
prints that identify the biological state of that cell. Molec-
ular profiling has rapidly become an effective approach to
further understanding of the phenotypes of tumor cells
[20,21]. Because the colony size of Tk mutants is deter-
mined by the growth rate of mutant cells, it would be
expected that there would be some difference in the
expression levels of one or more specific growth regula-
tion genes. Microarray analysis should allow us to meas-
ure gene expression in large and small colony mutants
and discern possible mechanisms that lead to the two
phenotypes based on the differences between the gene
expression profiles.
ArrayTrack software developed at the National Center for
Toxicological Research provides an integrated solution for
managing, analyzing, and interpreting microarray gene
expression data. It is MIAME (Minimum Information
about a Microarray Experiment) supportive for storing
both microarray data and experiment parameters associ-
ated with a pharmacogenomics or toxicogenomics study.
Using ArrayTrack, users can easily select a normalization
method and a statistical method applied to a stored
microarray dataset to cluster genes into different groups
according to expression profiles, to determine a list of dif-
ferentially expressed genes (significant genes), and to link
the gene list directly to pathways and gene ontology for
functional analysis. ArrayTrack is being integrated and fur-
ther refined at the U.S. FDA as a review tool for the phar-
macogenomics data submission program http://
www.fda.gov/nctr/science/centers/toxicoinformatics/BMC Bioinformatics 2006, 7(Suppl 2):S9
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ArrayTrack/index.htm. ArrayTrack is also freely available
to public [22].
In this study, previously isolated small and large Tk
mutants were evaluated for differences in gene expression
using microarray technology. We used this approach to
address the following 4 questions: (1) whether microarray
analysis using ArrayTrack could distinguish the two Tk
mutant phenotypes; (2) whether microarray analysis
could identify candidate genes that might contribute to
the phenotype difference; (3) whether genes altered in
their expression might be localized on chromosome 11
near the Tk gene; and (4) whether the results might pro-
vide insight into the underlying mechanisms responsible
for the two types of mutants. For this analysis, we selected
4 small and 4 large colony mutant samples from a previ-
ously conducted 3'-azido-3'-deoxythymidine (AZT)-treat-
ment [23]. These mutants were selected because they all
showed the same microsatellite pattern. They were LOH
for both Tk and D11Mit42 (see Figure 2). We used this
strategy for the mutant selection so that we could deter-
mine if the microarray approach, which evaluates individ-
ual gene expression, would provide a level of resolution
not provided by the microsatellite analysis. We found that
microarray analysis using ArrayTrack distinguished the
two different cellular phenotypes and identified a set of
candidate genes that are responsible for the colony size
phenotypes. Also, the expression of a high proportion of
genes located near the Tk gene on chromosome 11 was
differentially altered between the large and small colony
mutant samples, which might be the original reason for
the formation of two different sizes of colony mutants.
Materials and Methods
Cells and culture conditions
L5178Y/Tk+/--3.7.2C mouse lymphoma Tk-deficient
mutants were grown according to the methods described
by Chen and Moore [4]. Briefly, the basic medium was
Fischer's medium for leukemic cells of mice with L-
glutamine (Quality Biological Inc., Gaithersburg, MD)
supplemented with 10% heat-inactivated horse serum,
pluronic F68 (0.1%), sodium pyruvate (1 mM), penicillin
(100 U/ml), and streptomycin (100 μg/ml). The cultures
were maintained in a humidified incubator with 5% CO2
in air at 37°C. Unless otherwise noted, all culture supplies
were purchased from Invitrogen Life Technologies
(Carlsbad, CA).
Selection of large and small colony Tk mutants and 
expansion of mutant cells
Large and small colony mutants were selected from a
series of mutants isolated following AZT treatment [23].
An example of large and small colonies in selective
medium in 96-well plates is shown in Figure 1. The
mutants were selected based on the considerations
described in the introduction. All mutants showed the
same microsatellite LOH pattern (LOH at Tk and D11
Mit42 – see Figure 2) indicating that the chromosome
alteration might occur at the Tk locus and extend up to
58.5 cM.
In addition, only mutants whose growth rates were rela-
tively stable were chosen for microarray analysis of gene
expression. The average doubling time for the large colony
mutants was 9.6 ± 0.2 hours while the average doubling
time for the small colony mutants was 17.5 ± 0.4 hours (p
< 0.001, Student T-test).
RNA Isolation and cDNA Labeling
Total RNA was extracted from mutants whose cells were
collected at log stage of growth using Qiagen RNeasy kits
with on-column DNase digestion. The concentration and
quality of RNA samples were measured by a spectropho-
tometer and an Agilent 2100 Bioanalyzer (Agilent, Palo
Alto, CA). All the RNA samples were stored at -80°C until
used for microarray analysis.
The aminoallyl-indirect labeling protocol by The Institute
for Genomic Research (TIGR, Rockville, MD) was fol-
The loss of heterozygosity (LOH) pattern of all mouse lym- phoma Tk mutants (4 small and 4 large colony mutant sam- ples Figure 2
The loss of heterozygosity (LOH) pattern of all mouse lym-
phoma Tk mutants (4 small and 4 large colony mutant sam-
ples. The codes in the upper row are microsatellite loci on 
chromosome 11. The numbers in the middle row are the dis-
tances from the top of the chromosome to the locus in cM 
(centimorgan). The symbol ❍ indicates LOH and ● indicates 
that the locus retains heterozygosity.

Agl2 42 59 36 29 22 20 19 74
   	
 	    

        
Large and small colony Tk mutants in TFT selective medium Figure 1
Large and small colony Tk mutants in TFT selective medium. 
A. shows different size of colonies in a 96-well plate and B. 
displays a typical large colony mutant and a typical small col-
ony mutant.
A .         B .  BMC Bioinformatics 2006, 7(Suppl 2):S9
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lowed with a few modifications. Briefly, 10 μg of total
RNA was primed with 6 μg of random hexamer primers
(Invitrogen, Carlsbad, CA) in a final volume of 16.5 μl.
The RNA was reverse-transcribed in a 30 μl reaction con-
taining 0.5 mM dATP, dCTP, dGTP, 0.3 mM dTTP (Invit-
rogen) and 0.2 mM aminoallyl-dUTP (aa-dUTP,
Ambion), 40 U RNase inhibitor (Invitrogen), 400 U
Superscript II (Invitrogen), 10 mM DTT and 1X first strand
buffer at 42°C for 2 hours to generate aminoallyl-labeled
cDNA. The purified aminoallyl-cDNA was coupled with
either Cy3 or Cy5 monoreactive dyes (Amersham Phar-
macia, Piscataway, NJ). Uncoupled dyes were removed by
QIAquick PCR purification kit. cDNA yields and dye
incorporation efficiencies were determined using a Nano-
Drop spectrophotometer. A reference design was used in
which RNA sample from each large or small colony
mutant was labeled with Cy5 and paired with Mouse Uni-
versal Reference RNA (Stratagene, La Jolla, CA) labeled
with Cy3.
Hybridization and imaging
Pairs of Cy3 and Cy5 labeled cDNAs were dissolved in 60
μl of hybridization buffer (5× SSC, 0.1% SDS with 27%
formamide) and incubated with a mouse 20 k oligonucle-
otide microarray that was fabricated in-house at the NCTR
using oligonucleotides from MWG, Inc. (High Point, NC).
The hybridization was performed in hybridization cas-
settes (ArrayIt, Sunnyvale, CA) in a water bath at 50°C for
16–18 hours. The slides were then washed in pre-warmed
(30°C) 2X SSC (containing 0.1% SDS) for 5 minutes, 1X
SSC for 5 minutes, and 0.5X SSC for 5 minutes. The
hybridized slides were dried immediately by centrifuga-
tion and scanned with a GenePix 4000B scanner (Axon
Instruments, Sunnyvale, CA) at 10 μm resolution. The
resulting images were analyzed by measuring the fluores-
cence of all features on the slides using the GenePix Pro
6.0 software (Axon Instruments). The median fluores-
cence intensity of all the pixels within one feature was
taken as the intensity value for each feature.
Data analysis
The raw data were imported into ArrayTrack (NCTR/FDA)
and normalized using Total Intensity Normalization after
subtracting backgrounds. Expression ratios (sample/uni-
versal RNA) from 8 arrays (4 large colony and 4 small col-
ony mutant RNA samples) were log2-transformed. The
logged data were used for principal component analysis
(PCA), hierarchical cluster analysis (HCA), and statistical
analysis for identifying genes that were differentially
expressed in large versus small colony mutants. The Welch
T-test was used for determining significant changes in
gene expression between the large and small colony
mutant groups. Significant genes were selected with a cut-
off of p < 0.01 and fold change > 1.5. The selected genes
were further analyzed for their functions and networks
using Ingenuity Pathway Analysis (IPA, Ingenuity Systems
Inc., Redwood City, CA). Information on genes' chromo-
some locations were obtained using Gene Library within
ArrayTrack.
Results
Principal component analysis and hierarchical clustering 
of the gene expression profiles
Genome-wide expression profiles for 8 Tk mutant sam-
ples were generated using the mouse oligonucleotide
microarray. Principal components analysis (PCA) within
ArrayTrack was used to carry out an examination of the
relationship among the samples (Figure 3). A separation
between large and small colony mutants was clearly
observed. The large colonies are more tightly grouped
together while the small colonies more loosely grouped.
Hierarchical Cluster Analysis (HCA) using ArrayTrack also
revealed distinct grouping of the mutant samples accord-
ing to their colony size, suggesting that gene expression
patterns are different between the large and small colony
mutants (Figure 4).
Identification of differentially expressed genes between 
large and small colony Tk mutants
Welch T-test was used for determining significant changes
in gene expression between large and small colony
mutant groups. A volcano plot for differentially expressed
genes between large and small colony mutants is shown
in Figure 5. A group of 90 genes was found to be differen-
tially expressed with a cutoff (p < 0.01 and fold change >
1.5). Among the 90 genes, 15 genes were up-regulated and
75 genes were down-regulated when the gene expression
ratios in large colony mutants were compared to those in
small colony mutants (large/small). A complete list of
these genes can be found in Table 1. There were 431 genes
whose p-value was smaller than 0.01 without fold-change
cutoff and 1034 genes that have a fold-change greater than
1.5 without considering the p-value.
Pathway analysis of the significant genes
The selected genes were analyzed for their functions using
IPA that is integrated with ArrayTrack. Among the 90
genes, 50 genes were mapped to the IPA database and
were used for functional analysis. The 50 genes were
mapped to four different networks in the IPA database
(Table 2). The scores for all of the mapped networks were
higher than 19, indicating that the networks selected were
not due to random chance alone. (A score of 3 or greater
was considered significant at p < 0.001 level). These net-
works were associated with the following pathways: gene
expression, cell signaling, lymphatic system development
and function, cellular growth and proliferation, cell death
and cancer.BMC Bioinformatics 2006, 7(Suppl 2):S9
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Significant genes located on chromosome 11
The mouse lymphoma mutants are identified and isolated
because they have mutation(s) that involve the Tk gene
that is located at the distal end of chromosome 11. The
mutation can occur solely within the Tk gene or it may
also involve other genes on chromosome 11. While the
underlying difference between the small and large colony
mutants has remained elusive, it is clear that the slow
growth of the small colony mutants must be caused by an
alteration in the expression of one or more genes related
Principal component analysis (PCA) 3D view for gene expression profiles from 8 large and small colony Tk mutant samples Figure 3
Principal component analysis (PCA) 3D view for gene expression profiles from 8 large and small colony Tk mutant samples. 
The PCA is based on log2 ratios and the expression profiles are across all the 20,000 genes in the microarrays. The blue and 
red dots indicate large and small colony mutants, respectively. The first three principal components are plotted. The captured 
variances of PC1 (first principal component), PC2 (second principal component) and PC3 (third principal component; the label 
is not shown) were 25.5%, 17.4%, and 15.5%, respectively.BMC Bioinformatics 2006, 7(Suppl 2):S9
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to cell growth. It is expected that one or more genes
located near the Tk gene on chromosome 11 may have dif-
ferential expression in large and small colony mutants
because of an alteration of the DNA in the region around
the Tk gene. The Gene Library feature of ArrayTrack was
used to identify the significant genes located on chromo-
some 11. Among 90 significant genes, 10 of them were
found to be located on chromosome 11 (about 11%).
Interestingly, all these genes had a higher gene expression
in small colony mutants than in large colony mutants
(Table 1 and Figure 6). Among the total genes (20,000) in
the array, about 5.6% of them are located on chromo-
some 11 and no bias for up or down-regulation of genes
was found.
Discussion
The large and small colony Tk  mutants differ in their
growth kinetics. The cells from the small colony mutants
grow slowly while the cells from large colony mutants
grow at normal rates [5,9]. The relative proportion of
these two classes of mutants is mutagen dependent and
relates to the clastogenic, anuploidogenic and recombino-
genic potential of the chemical. Despite extensive molec-
ular genetic and cytogenetic evaluation of a large number
of mutants, the fundamental mechanistic difference(s)
between the two phenotypes is not known. To explore the
biological difference between the two types of Tk mutants,
four large colony mutant samples with an average dou-
bling time of 9.6 ± 0.2 hours and four small colony
mutant samples with an average doubling time of 17.5 ±
0.4 hours were examined by microarray gene expression
analysis.
PCA and HCA of the gene expression profiles from these
mutant samples showed that the samples were clearly sep-
arated into two groups based on their phenotype of col-
ony sizes. Given that both PCA and HCA were conducted
using all of the genes on the microarray (20K) without fil-
tering, this finding is very significant, indicating a high
quality of the microarray experiment and strong biologi-
cal relevance. The results can be interpreted as evidence
for the biological similarity within each size group and
biological differences between the two different size col-
ony mutants. Also the results from PCA (Figure 3) showed
that the gene expression patterns in the large colony group
of mutants were very homogeneous while the expression
patterns from the small colony group of mutants were rel-
atively heterogeneous. These patterns reflect the variabil-
ity of the colony size in the two groups. Generally, large
colony mutants are similar in size to wild-type colonies;
the growth rate of these cells is also similar. The growth
rate of cells in the small colony mutants is slower and
more variable than wild-type cells. The standard deviation
of the growth rate of cells from the small colony mutant
samples was greater than that for cells from the large col-
ony mutants.
Expression of 90 genes was significantly altered between
large and small colony mutants. When comparing the
expression of large colony mutants to small colony
mutants, 15 genes were up-regulated and 75 genes were
down-regulated. This bias might result from the character-
istics of these genes. Most of these genes are involved in
regulation of growth. Twenty-two of 50 genes mapped
into IPA database were involved in the regulation of apop-
tosis. They are Cdh2, Cdkn2A, Chrm1, Cspg2, Ets1, Fgfr1,
Gata6, Grn, Ifi202b, Il17rd, Irf2, Lamb2, Neu3, Nppa,
Pdgfra, Ptn, Ptprc, Rag2, Sema3b, Stat1, Tgfbr2, and
Tp53inp1. Expression of 18 genes among them was
higher in small colony mutants than large colony
Hierarchical clustering of large and small colony mutant samples Figure 4
Hierarchical clustering of large and small colony mutant samples. Ward's Minimum Variance method was used. Clustering is 
based on log2 ratios and the expression profiles are across all the 20,000 genes in the microarrays.BMC Bioinformatics 2006, 7(Suppl 2):S9
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mutants. This pattern of expression suggests that more
apoptosis occurred in the small colony mutants, leading
to the slow growth of the cells.
Consistent with the growth rate phenotype is the finding
that nearly all significant genes that can be found in IPA
database were mapped into networks that were related to
cell growth (see Table 2).
Genes of particular interest in this group are recombina-
tion activating gene 2 (Rag2) and cyclin-dependent kinase
inhibitor 2A (Cdkn2a). Because a large portion of Tk
mutants may result from recombinational events, we have
proposed that the mouse lymphoma cells have a high
recombinase activity. The Rag1 and Rag2 genes are neces-
sary for V(D)J recombination [24,25]. Also, Rag2 is neces-
sary for lymphocyte maturation and growth [26,27]. A
2.21-fold lower activity of Rag2 gene expression in small
colony mutant (Table 1) would restrict the cell growth of
small colony mutants. Because the large colony cells grow
at a similar growth rate as the wild type mouse lymphoma
cells, the high expression of Rag2 in large colony cells
might suggest that mouse lymphoma cells have an ele-
vated level of the recombinase activity and these cells
might be particularly sensitive to recombination and
therefore particularly effective in detecting chemicals that
induce recombination. Cdkn2a is known to be an impor-
tant tumor suppressor gene [28] and generates several
transcript variants that function as inhibitors of CDK4
kinase [28,29]. This protein also sequesters MDM1, a pro-
tein involved in the degradation of p53, and thus may
serve to stabilize p53 [30]. Therefore, this protein func-
tions in cell cycle control and it is frequently mutated or
deleted in a wide variety of tumors [31-35]. A 2.02-fold
higher expression activity of this tumor suppressor gene in
small colony mutants (Table 1) would favor a slower
growth of those cells than the large colony cells.
Of particular interest, the significant genes were dispro-
portionally distributed in the vicinity of the Tk gene on
chromosome 11 with a higher expression level in small
mutant colony mutants than in large colony mutants. Ten
of the significant genes were located on chromosome 11.
However, if the genes were distributed on the chromo-
somes proportionally, there would have been about 2
genes with up-regulation of expression in the small col-
ony mutants on chromosome 11. Moreover, 7 of the 10
genes were located within 20 cM of the Tk gene (Figure 6).
This gene distribution pattern may be explained by chro-
mosomal location rather than by gene function, suggest-
ing a regional change in gene expression. Further, this
suggests that the type of DNA alteration that inactivates
the Tk gene in the small colony mutants is responsible for
this regional change in gene activity. Although the micro-
satellite LOH pattern in the D and E bands of chromo-
some 11 (Figure 2 and Figure 6) was the same for all the
mutants, the gene expression in this region appeared sig-
nificantly different between the large and small colony
mutants.
Conclusion
The PCA and HCA showed that the gene expression pro-
files from the mutant samples were clearly separated into
two groups based on their colony sizes. This cluster pat-
tern indicates biological similarity within each mutant
group and biological difference between the two different
colony size mutants. Statistical and functional analysis of
the profiles identified a set of genes whose expression was
differentially altered between large and small colony
mutants. Most of these genes are responsible for regula-
tion of cell growth that would be expected to influence the
cell growth rate and the colony sizes. In addition, we
found a number of significant genes that were dispropor-
tionally concentrated on an area of chromosome 11
where there was loss of heterozygosity. These findings sug-
gest that the Tk chromosome mutations in the small Tk
colony mutants result in alterations in gene expression for
genes located near the Tk gene. This same altered gene
expression does not occur in the large colony mutants.
This finding is particularly interesting because the micros-
atellite LOH analysis indicates no difference between the
small and large colony mutants. Our analysis demon-
strates that the utility of microarray analysis using
ArrayTrack provides a gene level analysis of the two cellu-
lar phenotypes. Using this tool, we have identified genes
that appear to be related to the colony size phenotype. The
analysis of additional mutants would be expected to pro-
vide further information and may elucidate the underly-
ing difference between the small and large colony Tk
mutants.
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Volcano plot for differentially expressed genes between large and small colony mutants Figure 5
Volcano plot for differentially expressed genes between large and small colony mutants. The plot is based on log2 ratios and 
the expression profiles are across all the 20,000 genes in the microarrays. A gene is identified as significantly altered if the p-
value is smaller than 0.01 and fold change is greater than 1.5. Red dots indicate significant genes; pink dots indicate genes that 
have p < 0.01 and fold changes < 1.5; yellow dots indicate genes that have p > 0.01 and fold change > 1.5; and black dots indi-
cate genes that have p > 0.01 and fold change < 1.5.BMC Bioinformatics 2006, 7(Suppl 2):S9
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Table 1: Genes differentially expressed between large and small colony mutants (p < 0.01; fold change > 1.5).
Locus ID Gene Name P Value Fold Change Description
109815 H47 0.0000 -1.55 histocompatibility 47
93707 Pcdhgc4 0.0000 -1.93 protocadherin gamma subfamily C, 4
100121 5730495N10Rik 0.0001 11.68 tudor domain containing 7
23936 Lynx1 0.0001 -1.51 Ly6/neurotoxin 1
74558 9130002C22Rik 0.0001 -2.18 GTPase, very large interferon inducible 1
77705 9230104L09Rik 0.0002 -2.10 RIKEN cDNA 9230104L09 gene
18028 Nfib 0.0002 -2.19 nuclear factor I/B
14081 Acsl1 0.0003 1.55 acyl-CoA synthetase long-chain family member 1
12669 Chrm1 0.0003 -1.53 cholinergic receptor, muscarinic 1, CNS
14824* Grn 0.0003 -4.26 granulin
60599 Trp53inp1 0.0004 -1.54 transformation related protein 53 inducible nuclear protein 1
268490* 1110032E16Rik 0.0006 -1.53 RIKEN cDNA 2600001B17 gene
68473 1110003E08Rik 0.0006 -1.63 MOB1, Mps One Binder kinase activator-like 1A (yeast)
16391 Isgf3g 0.0006 -1.93 interferon dependent positive acting transcription factor 3 gamma
14182 Fgfr1 0.0008 -1.53 fibroblast growth factor receptor 1
71723 Dhx34 0.0010 1.73 DEAH (Asp-Glu-Ala-His) box polypeptide 34
494468 MGC38735 0.0010 -1.51 hypothetical protein
20742* Spnb2 0.0011 -1.50 spectrin beta 2
19374 Rag2 0.0012 2.21 recombination activating gene 2
18103* Nme2 0.0012 -1.50 expressed in non-metastatic cells 2, protein
66359 2310005N03Rik 0.0014 1.56 RIKEN cDNA 2310005N03 gene
194367 0.0015 -3.69 Not found
72700 2810040O04Rik 0.0017 -1.73 Zinc fingerprotein 618
231293 C130090K23Rik 0.0019 -2.14 RIKEN cDNA C130090K23 gene
27660 1700088E04Rik 0.0021 -1.66 RIKEN cDNA 1700088E04 gene
55932 Gbp3 0.0022 -1.91 guanylate nucleotide binding protein 4
19245 Ptp4a3 0.0024 1.77 protein tyrosine phosphatase 4a3
17722 Nd6 0.0024 -1.53 NADH dehydrogenase subunit 6
12578 Cdkn2a 0.0024 -2.02 cyclin-dependent kinase inhibitor 2A
20846 Stat1 0.0026 -1.52 signal transducer and activator of transcription 1
77015 2700082O15Rik 0.0026 -1.61 metallophosphoesterase domain containing 2
50877 Neu3 0.0026 -1.65 neuraminidase 3
67998* 1300010M03Rik 0.0026 -1.88 RIKEN cDNA 1300010M03 gene
171463 Il17rd 0.0026 -2.72 interleukin 17 receptor D
20363 Sepp1 0.0026 -3.05 selenoprotein P, plasma, 1
12833 Col6a1 0.0026 -6.94 procollagen, type VI, alpha 1
13612 Edil3 0.0028 -1.54 EGF-like repeats and discoidin I-like domains 3
77773 A330103N21Rik 0.0028 -1.77 RIKEN cDNA A330103N21 gene
228543 Arhv 0.0032 -2.04 ras homolog gene family, member V
230899 Nppa 0.0033 -1.52 natriuretic peptide precursor type A
3337208 Cytb 0.0033 -1.65 cytochrome b
12558 Cdh2 0.0037 -1.57 cadherin 2
192231* Clp1 0.0037 -1.67 hexamethylene bis-acetamide inducible 1
93875 Pcdhb4 0.0041 -1.58 protocadherin beta 4
72080 2010317E24Rik 0.0044 1.51 RIKEN cDNA 2010317E24 gene
27360 Add3 0.0045 -1.57 adducin 3 (gamma)
14431 Gamt 0.0046 -1.65 guanidinoacetate methyltransferase
13841 Epha7 0.0047 -1.55 Eph receptor A7
21356 Tapbp 0.0047 -1.63 TAP binding protein
26388 Ifi202b 0.0047 -4.15 interferon activated gene 202B
77974 Rdh12 0.0050 -1.60 retinol dehydrogenase 12
11542 Adora3 0.0050 -1.76 adenosine A3 receptor
16909 Lmo2 0.0050 -1.84 LIM domain only 2
16779 Lamb2 0.0051 2.50 laminin, beta 2
19264 Ptprc 0.0051 1.78 protein tyrosine phosphatase, receptor type, C
57754 1500001H12Rik 0.0051 -1.50 RIKEN cDNA 1500001H12 gene
225849 Ppp2r5b 0.0051 -1.88 protein phosphatase 2, regulatory subunit B (B56), beta isoform
15950 Ifi203 0.0052 -1.65 interferon activated gene 203
258568 MOR202-20 0.0053 1.68 olfactory receptor 1457BMC Bioinformatics 2006, 7(Suppl 2):S9
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Table 2: List of Ingenuity networks generated by mapping the focus genes that were differentially expressed between large and small 
colony mutants.
Network Genes* Score# Focus Genes Top Functions
1 Add3, Adora3, Agt, Asf1b, Cdkn1b, Cdkn2a, Cks1b, 
Col6a1, Col6a2, Cspg2, Ctcf, Cyp11b2, Egfr, Eps8, Erbb2, 
Fbn1, Fgfr1, Gbp4, Gpc1, Hmga2, Il17rd, Irf4, Mell1, 
Nfatc2, Nfib, Nppa, Npr3, P4ha2, Ptrf, Rag2, Tgfbr2, 
Tlk2, Top1, Tp53inp1, Wap
25 15 Cellular Growth and Proliferation, Cancer, Cell 
Death
2 Acsl1, Angpt1, Btg1, Btg2, Ccnt1, Ccnt2, Cdk9, Cebpa, 
Chrm1, Dgkz, Efna1, Elf1, Epha7, Fbl, Grn, His1, Ifi203, 
Lamb2, Mapk1, Mmp17, Myc, Nme2, Oas1, Ptprc, Ptx3, 
Rasgrp1, Rn7sk, Rock1, Slpi, Spry4, Sytl1, Tapbp, Tdrd7, 
Tnf, Trib1
21 13 Gene Expression, Cellular Development, Cell-
To-Cell Signaling and Interaction
3 Alox15, Btg1, Cdkn1a, Cks1b, Col6a1, Col6a2, Col6a3, 
Ctcf, Ebi3, Fgf13, Gata6, Gvin1, Ifi35, Ifi202b, Ifna, Ifne1, 
Ifng, Il15, Il12rb1, Il17f, Il27ra, Isgf3g, Mylk, Nd6, Ndufs4, 
Pdgfc, Pdgfra, S100a11, Sema3b, Sepp1, Stat1, Stat4, 
Tgfb1, Trim30, Znf467
19 12 Cancer, Cell Death, Cellular Growth and 
Proliferation
4 Casp3, Cckbr, Cd1d, Cdh2, Ctcf, Ctnna2, Ctnnb1, Ctnnd2, 
Cyp24a1, Edil3, Ets1, Gypa, Il2, Invs, Lmo2, Mdm4, 
Mgat5, Neu3, Nf2, Pag, Pitx2, Ppp2ca, Ppp2cb, Ppp2r2c, 
Ppp2r5b, Ptn, Ptp4a3, Ptprc, Scn5a, Slc4a1, Snrpd1, 
Sptbn1, Tbxas1, Tp53, Tuba1
19 12 Cellular Development, Hematological System 
Development and Function, Immune and 
Lymphatic System Development and Function
Note: * Bold genes are those mapped by the significant genes. # A score of 3 or greater was considered significant (p < 0.001)
23871 Ets1 0.0058 1.54 E26 avian leukemia oncogene 1, 5' domain
21813 Tgfbr2 0.0058 -1.50 transforming growth factor, beta receptor II
65116 Prrg2 0.0060 -1.52 proline-rich Gla (G-carboxyglutamic acid) polypeptide 2
192231 Clp1 0.0060 -1.88 hexamethylene bis-acetamide inducible 1
20641 Snrpd1 0.0062 1.54 small nuclear ribonucleoprotein D1
252868* Oppo1 0.0062 -1.52 outer dense fiber of sperm tails 4
380832 Tcrg-C 0.0066 2.17 T-cell receptor gamma, constant region
24086* Tlk2 0.0067 -1.61 tousled-like kinase 2 (Arabidopsis)
67775 5830458K16Rik 0.0068 -1.64 RIKEN cDNA 5830458K16 gene
15042 H2-T24 0.0069 -1.68 histocompatibility 2, T region locus 24
24066 Spry4 0.0071 -1.51 sprouty homolog 4 (Drosophila)
15425 Hoxc6 0.0071 -1.65 homeo box C6
14934 Gypa 0.0074 2.57 glycophorin A
230587 Gli6 0.0074 -1.55 GLIS family zinc finger 1
19242 Ptn 0.0074 -1.77 pleiotrophin
211770 A530090O15Rik 0.0077 -1.51 tribbles homolog 1 (Drosophila)
20128 Trim30 0.0077 -1.70 tripartite motif protein 30
22441 Xlr 0.0079 -1.73 X-linked lymphocyte-regulated complex
66205 1110055L24Rik 0.0079 -1.96 CD302 antigen
70110* 2010008K16Rik 0.0081 -1.58 interferon-induced protein 35
214855 D430024K22Rik 0.0084 -1.62 AT rich interactive domain 5A (Mrf1 like)
13003 Cspg2 0.0086 -1.70 chondroitin sulfate proteoglycan 2
70355* Gprc5c 0.0087 -1.82 G protein-coupled receptor, family C, group 5, member C
67974 5730405I09Rik 0.0089 1.58 RIKEN cDNA 5730405I09 gene
20347 Sema3b 0.0091 -1.53 sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B
16364 Irf4 0.0092 -1.60 interferon regulatory factor 4
18595 Pdgfra 0.0095 -2.77 platelet derived growth factor receptor, alpha polypeptide
14465 Gata6 0.0097 -1.53 GATA binding protein 6
Note: Three unknown genes are not included. * indicates the gene is located on chromosome 11.
Table 1: Genes differentially expressed between large and small colony mutants (p < 0.01; fold change > 1.5). (Continued)BMC Bioinformatics 2006, 7(Suppl 2):S9
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Table 3: Location and function of the significant genes located on chromosome 11.
Gene Name Location Gene product and function
1110032E16Rik E1 Hypothetical protein LOC268490 with unknown function
1300010M03Rik D Hypothetical protein LOC67998 with unknown function
2010008K16Rik D Interferon-induced protein with unknown function
Clp1 E1 Cleavage and polyadenylation factor CF I component involved in pre-mRNA 3'-end processing
Gprc5c E2 G protein-coupled receptor, family C, group 5, member C with unknown function
Grn E1 Granulin that acts as inhibitors, stimulators, or have dual actions on cell growth.
Nme2 C Expressed in non-metastatic cells 2, protein involves in cell proliferation.
Oppo1 B3 Outer dense fiber of sperm tails 4 with unknown function.
Spnb2 A3.3 Spectrin involving disruption, proliferation of cells.
Tlk2 E1 Tousled-like kinase 2 that function as regulation of chromatin assembly or disassembly; protein amino acid 
phosphorylation; response to DNA damage stimulus; cell cycle; intracellular signaling cascade; chromatin modification
Map for chromosome 11 genes whose expression was significantly altered Figure 6
Map for chromosome 11 genes whose expression was significantly altered. The position of Tk1 gene in red is also shown for 
comparison. The right ruler indicates distance in cM (centimorgan) from top of the chromosome.
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